Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies

Autor: Bikdeli, Behnood a, b, c, ⁎, Talasaz, Azita H. d, Rashidi, Farid e, Sharif-Kashani, Babak f, g, Farrokhpour, Mohsen h, Bakhshandeh, Hooman i, Sezavar, Hashem j, Dabbagh, Ali k, Beigmohammadi, Mohammad Taghi l, Payandemehr, Pooya m, Yadollahzadeh, Mahdi h, Riahi, Taghi j, Khalili, Hossein n, Jamalkhani, Sepehr o, w, Rezaeifar, Parisa e, Abedini, Atefeh p, Lookzadeh, Somayeh p, Shahmirzaei, Shaghayegh m, Tahamtan, Ouria e, Matin, Samira e, Amin, Ahmad i, Parhizgar, Seyed Ehsan i, Jimenez, David q, r, s, Gupta, Aakriti c, t, Madhavan, Mahesh V. c, t, Parikh, Sahil A. c, t, Monreal, Manuel u, Hadavand, Naser i, Hajighasemi, Alireza d, Maleki, Majid i, Sadeghian, Saeed d, Mohebbi, Bahram i, Piazza, Gregory a, Kirtane, Ajay J. c, t, Lip, Gregory Y.H. v, w, Krumholz, Harlan M. b, x, y, Goldhaber, Samuel Z. a, Sadeghipour, Parham z, aa, ⁎⁎
Zdroj: In Thrombosis Research December 2020 196:382-394
Databáze: ScienceDirect